Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.
Autor: | Celik Z; Department of Pharmacology, Istanbul University Faculty of Pharmacy, Istanbul, Turkey; Department of Pharmacology, Istanbul University, Institute of Graduate Studies in Health Sciences, Istanbul, Turkey., Ozen G; Department of Pharmacology, Istanbul University Faculty of Pharmacy, Istanbul, Turkey., Sunar S; Department of Pharmacology, Istanbul University Faculty of Pharmacy, Istanbul, Turkey; Department of Pharmacology, Istanbul University, Institute of Graduate Studies in Health Sciences, Istanbul, Turkey., Turkyilmaz S; Department of Cardiovascular Surgery, Bakirkoy Dr. Sadi Konuk Education and Research Hospital Bakirkoy, Istanbul, Turkey., Turkyilmaz G; Department of Cardiovascular Surgery, Bakirkoy Dr. Sadi Konuk Education and Research Hospital Bakirkoy, Istanbul, Turkey., Kavala AA; Department of Cardiovascular Surgery, Bakirkoy Dr. Sadi Konuk Education and Research Hospital Bakirkoy, Istanbul, Turkey., Teskin O; Department of Cardiovascular Surgery, Biruni University, Istanbul, Turkey., Dogan BSU; Department of Pharmacology, Istanbul University Faculty of Pharmacy, Istanbul, Turkey., Topal G; Department of Pharmacology, Istanbul University Faculty of Pharmacy, Istanbul, Turkey. Electronic address: gtopal@istanbul.edu.tr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2023 Dec; Vol. 169, pp. 106786. Date of Electronic Publication: 2023 Oct 06. |
DOI: | 10.1016/j.prostaglandins.2023.106786 |
Abstrakt: | Specialized pro-resolving lipid mediators (SPMs), derived from polyunsaturated fatty acids are important mediators in the resolution of inflammation. Recent studies have focused on the effects of SPMs in cardiovascular health and diseases. However, little is known about the effect SPMs on human vascular tone. Therefore, in this study it is aimed to investigate the effect of various SPMs including resolvin D- and E-series, maresin-1 (MaR1) and lipoxin-A4 (LxA4) on the vascular tone of human isolated saphenous vein (SV) preparations under inflammatory conditions. In addition, we aimed to evaluate the effects of SPMs on the release of pro-inflammatory mediators, monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF- α) from human SV. Pretreatment of isolated of human SV with resolvin E1 (RvE1), resolvin D1 (RvD1) and MaR1 (100 nM, 18 h) significantly reduced the contractile responses to thromboxane A2 mimetic, U46619 whereas pretreatment with LxA4 and RvD2 (100 nM, 18 h) had no significant effect on the vascular tone of SV. Moreover, RvE1, RvD1 and MaR1 but not LxA4 and RvD2 (100 nM, 18 h) pretreatment diminished the release of MCP-1 and TNF-α from SV. In conclusion, our findings suggest that pre-treatment with RvE1, RvD1, and MaR1 could have potential benefits in decreasing graft vasospasm and vascular inflammation in SV. Competing Interests: Conflicts of Interest The authors declare no conflict of interest. (Copyright © 2023 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |